pindolol has been researched along with Disease, Pulmonary in 2 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorow, P | 1 |
| Weiss, T | 1 |
| Felix, R | 1 |
| Schmutzler, H | 1 |
| Park, PG | 1 |
| Merryman, J | 1 |
| Orloff, M | 1 |
| Schuller, HM | 1 |
2 other studies available for pindolol and Disease, Pulmonary
| Article | Year |
|---|---|
The influence of propranolol, metoprolol, and mepindolol on mucociliary clearance in coronary heart disease patients without pulmonary disease.
Topics: Cilia; Coronary Disease; Female; Humans; Lung; Lung Diseases; Male; Metoprolol; Middle Aged; Mucous | 1984 |
Beta-adrenergic mitogenic signal transduction in peripheral lung adenocarcinoma: implications for individuals with preexisting chronic lung disease.
Topics: Adenocarcinoma; Cell Division; Colforsin; Cyclic AMP; Epinephrine; Humans; In Vitro Techniques; Iodo | 1995 |